chr18-33578904-G-GCGTCCGGGAC
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_030632.3(ASXL3):c.54+222_54+231dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00482 in 205,018 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0063 ( 8 hom., cov: 31)
Exomes 𝑓: 0.00055 ( 0 hom. )
Consequence
ASXL3
NM_030632.3 intron
NM_030632.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.672
Genes affected
ASXL3 (HGNC:29357): (ASXL transcriptional regulator 3) This gene encodes a protein containing a plant homeodomain (PHD) zinc finger domain that plays a role in the regulation of gene transcription. The encoded protein has been shown to negatively regulate lipogenesis by binding to and inhibiting the transcriptional activity of two nuclear hormone receptors, oxysterols receptor LXR-alpha (LXRalpha) and thyroid hormone receptor beta (TRbeta). The encoded protein may also inhibit histone deubiquitination. Mutations in this gene have been identified in human patients with Bainbridge-Ropers syndrome, which is characterized by feeding difficulties, developmental delay and other features. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 18-33578904-G-GCGTCCGGGAC is Benign according to our data. Variant chr18-33578904-G-GCGTCCGGGAC is described in ClinVar as [Likely_benign]. Clinvar id is 1203778.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00631 (959/152034) while in subpopulation AFR AF= 0.022 (915/41548). AF 95% confidence interval is 0.0208. There are 8 homozygotes in gnomad4. There are 477 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 959 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASXL3 | NM_030632.3 | c.54+222_54+231dup | intron_variant | ENST00000269197.12 | |||
ASXL3 | XM_005258356.2 | c.54+222_54+231dup | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASXL3 | ENST00000269197.12 | c.54+222_54+231dup | intron_variant | 5 | NM_030632.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00623 AC: 946AN: 151918Hom.: 6 Cov.: 31
GnomAD3 genomes
AF:
AC:
946
AN:
151918
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000547 AC: 29AN: 52984Hom.: 0 Cov.: 0 AF XY: 0.000485 AC XY: 14AN XY: 28838
GnomAD4 exome
AF:
AC:
29
AN:
52984
Hom.:
Cov.:
0
AF XY:
AC XY:
14
AN XY:
28838
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00631 AC: 959AN: 152034Hom.: 8 Cov.: 31 AF XY: 0.00642 AC XY: 477AN XY: 74318
GnomAD4 genome
AF:
AC:
959
AN:
152034
Hom.:
Cov.:
31
AF XY:
AC XY:
477
AN XY:
74318
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 02, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at